Thurman J. Rodgers - 28 Aug 2025 Form 4 Insider Report for Enovix Corp (ENVX)

Signature
/s/ Arthi Chakravarthy, Attorney-in-Fact for Thurman J. Rodgers
Issuer symbol
ENVX
Transactions as of
28 Aug 2025
Net transactions value
-$1,587,700
Form type
4
Filing time
02 Sep 2025, 21:12:48 UTC
Previous filing
15 Aug 2025
Next filing
19 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rodgers Thurman J Director, 10%+ Owner C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT /s/ Arthi Chakravarthy, Attorney-in-Fact for Thurman J. Rodgers 02 Sep 2025 0001183967

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENVX Warrant (Right to Buy) Sale $832,174 -655,255 -34% $1.27 1,259,211 28 Aug 2025 Common Stock, par value $0.0001 655,255 $8.75 Trust F1, F2, F3, F4
transaction ENVX Warrant (Right to Buy) Sale $755,527 -1,259,211 -100% $0.6000* 0 29 Aug 2025 Common Stock, par value $0.0001 1,259,211 $8.75 Trust F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 relates to sales of publicly-traded warrants (the "Warrants") previously distributed to the Reporting Person. The Warrants were distributed by the Issuer on July 21, 2025 at no cost to the Reporting Person, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement dated July 21, 2025 between the Issuer and Computershare Trust Company N.A., as warrant agent (the "Warrant Agreement").
F2 In accordance with the Warrant Agreement, the original expiration date ceased to be exercisable at 5:00 p.m. New York City time on October 1, 2026 (the Expiration Date), subject to automatic acceleration upon satisfaction of the early expiration price condition. On August 28, 2025, the early expiration price condition was met and the expiration date for the warrants was accelerated to be on August 29, 2025. The Warrants was ceased to be exercisable prior to 5:00pm New York City time on August 29, 2025.
F3 The price reported in Column 8 is a weighted-average price. The shares were sold in multiple transactions ranging from $1.20 to $1.44, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The remaining Warrants are held by the Trust for which the Reporting Person is a trustee and has voting and dispositive power over the Warrants.
F5 The price reported in Column 8 is a weighted-average price. The shares were sold in multiple transactions ranging from $0.59 to $0.67, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.